Dickkopf (Dkk)-3, a member of the Dkk family of Wnt antagonists, can reduce the cytoplasmic accumulation of β-catenin in Saos-2 osteosarcoma cells and inhibit TCF-4 activity in PC12 rat pheochromocytoma cells [34]. Here, TCF4 is linked to osteosarcoma.